Skip to main content
Erschienen in: AIDS and Behavior 7/2019

25.09.2018 | Original Paper

Representations of Pre-exposure Prophylaxis, Informal Antiretroviral Medication Use for HIV Prevention, and Diversion on Geosocial Networking Apps among Men Who Have Sex with Men

verfasst von: Mance E. Buttram, Steven P. Kurtz

Erschienen in: AIDS and Behavior | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

The use of geosocial networking applications (e.g., Grindr) among men who have sex with men (MSM) is common. Yet scant research has examined how antiretroviral medications (ARVs)—including informal use—diversion and pre-exposure prophylaxis (PrEP) are presented inside of the applications. The present study examines this phenomenon. Data are drawn from a qualitative study (N = 39) of the scope and magnitude of the informal market of ARV use for HIV prevention among MSM. Twenty-five participants reported seeing references to ARVs inside the applications. Men described geosocial networking application users’ presentations of ARVs as being related to: PrEP use among HIV-negative MSM, the sale and/or use of illicit drugs (e.g., methamphetamine), informal trade/sale for HIV-prevention, and PrEP use among HIV-positive men. Findings suggest continued desire for and acceptability of PrEP as HIV prevention tool and that geosocial networking apps are being used to facilitate the exchange and informal use of ARVs for HIV-prevention. Geosocial networking applications represent a promising and important platform to educate MSM about safe and effective use of PrEP and the risks related to diversion and informal ARV use.
Literatur
1.
Zurück zum Zitat Young SD, Szekeres G, Coates T. The relationship between online social networking and sexual risk behaviors among men who have sex with men (MSM). PLoS ONE. 2013;8(5):e62271.CrossRefPubMedPubMedCentral Young SD, Szekeres G, Coates T. The relationship between online social networking and sexual risk behaviors among men who have sex with men (MSM). PLoS ONE. 2013;8(5):e62271.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Grosskopf NA, Le Vasseur MT, Glaser DB. Use of the Internet and mobile-based “apps” for sex-seeking among men who have sex with men in New York City. Am J Mens Health. 2014;8(6):510–20.CrossRefPubMed Grosskopf NA, Le Vasseur MT, Glaser DB. Use of the Internet and mobile-based “apps” for sex-seeking among men who have sex with men in New York City. Am J Mens Health. 2014;8(6):510–20.CrossRefPubMed
3.
Zurück zum Zitat Rice E, Holloway I, Winetrobe H, et al. Sex risk among young men who have sex. J AIDS Clin Res. 2012;S4:005. Rice E, Holloway I, Winetrobe H, et al. Sex risk among young men who have sex. J AIDS Clin Res. 2012;S4:005.
4.
Zurück zum Zitat Landovitz RJ, Tseng C-H, Weissman M, et al. Epidemiology, sexual risk behavior, and HIV prevention practices of men who have sex with men using Grindr in Los Angeles, California. J Urban Health. 2013;90(4):729–39.CrossRefPubMed Landovitz RJ, Tseng C-H, Weissman M, et al. Epidemiology, sexual risk behavior, and HIV prevention practices of men who have sex with men using Grindr in Los Angeles, California. J Urban Health. 2013;90(4):729–39.CrossRefPubMed
5.
Zurück zum Zitat Holloway IW, Rice E, Gibbs J, et al. Acceptability of smartphone application-based HIV prevention among young men who have sex with men. AIDS Behav. 2014;18(2):285–96.CrossRefPubMedPubMedCentral Holloway IW, Rice E, Gibbs J, et al. Acceptability of smartphone application-based HIV prevention among young men who have sex with men. AIDS Behav. 2014;18(2):285–96.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Goedel WC, Halkitis PN, Greene RE, et al. HIV risk behaviours, perceptions, and testing and preexposure prophylaxis (PrEP) awareness/use in Grindr-using men who have sex with men in Atlanta, Georgia. J Assoc Nurses AIDS Care. 2016;27(2):133–42.CrossRefPubMed Goedel WC, Halkitis PN, Greene RE, et al. HIV risk behaviours, perceptions, and testing and preexposure prophylaxis (PrEP) awareness/use in Grindr-using men who have sex with men in Atlanta, Georgia. J Assoc Nurses AIDS Care. 2016;27(2):133–42.CrossRefPubMed
7.
Zurück zum Zitat Winetrobe H, Rice E, Bauermeister J, et al. Associations of unprotected anal intercourse with Grindr-met partners among Grindr-using men who Have sex with men in Los Angeles. AIDS Care. 2014;26(10):1303–8.CrossRefPubMed Winetrobe H, Rice E, Bauermeister J, et al. Associations of unprotected anal intercourse with Grindr-met partners among Grindr-using men who Have sex with men in Los Angeles. AIDS Care. 2014;26(10):1303–8.CrossRefPubMed
8.
Zurück zum Zitat Eaton LA, Maksut JL, Gamarel KE, Siembida EJ, Driffin DD. Online sex partner meeting venues as a risk factor for testing HIV positive among a community-based sample of Black men who have sex with men. Sex Transm Dis. 2016;43(6):360–4.CrossRefPubMed Eaton LA, Maksut JL, Gamarel KE, Siembida EJ, Driffin DD. Online sex partner meeting venues as a risk factor for testing HIV positive among a community-based sample of Black men who have sex with men. Sex Transm Dis. 2016;43(6):360–4.CrossRefPubMed
9.
Zurück zum Zitat Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.CrossRefPubMedPubMedCentral Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Holloway IW, Dougherty R, Gidner J, et al. PrEP uptake, adherence, and discontinuation among California YMSM using geosocial networking applications. J Acquir Immune Defic Syndr. 2017;74(1):15–20.CrossRefPubMedPubMedCentral Holloway IW, Dougherty R, Gidner J, et al. PrEP uptake, adherence, and discontinuation among California YMSM using geosocial networking applications. J Acquir Immune Defic Syndr. 2017;74(1):15–20.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Goedel WC, Halkitis PN, Greene RE, Duncan DT. Correlates of awareness of nd willingness to use pre-exposure prophylaxis (PrEP) in gay, bisexual, and other men who have sex with men who use geosocial-networking smartphone applications in New York City. AIDS Behav. 2016;20(7):1435–42.CrossRefPubMed Goedel WC, Halkitis PN, Greene RE, Duncan DT. Correlates of awareness of nd willingness to use pre-exposure prophylaxis (PrEP) in gay, bisexual, and other men who have sex with men who use geosocial-networking smartphone applications in New York City. AIDS Behav. 2016;20(7):1435–42.CrossRefPubMed
12.
Zurück zum Zitat Rosengren AL, Huang E, Daniels J, et al. Feasibility of using Grindr to distribute HIV self-test kits to men who have sex with men in Los Angeles, California. Sex Health. 2016;13(4):389–92.CrossRef Rosengren AL, Huang E, Daniels J, et al. Feasibility of using Grindr to distribute HIV self-test kits to men who have sex with men in Los Angeles, California. Sex Health. 2016;13(4):389–92.CrossRef
13.
Zurück zum Zitat Czarny HN, Broaddus MR. Acceptability of HIV prevention information delivered through established geosocial networking mobile applications to men who have sex with men. AIDS Behav. 2017;21(11):3122–318.CrossRefPubMedPubMedCentral Czarny HN, Broaddus MR. Acceptability of HIV prevention information delivered through established geosocial networking mobile applications to men who have sex with men. AIDS Behav. 2017;21(11):3122–318.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Inciardi JA, Surratt HL, Kurtz SP, Burke JJ. The diversion of prescription drugs by health care workers in Cincinnati, Ohio. Subst Use Misuse. 2006;41(2):255–64.CrossRefPubMed Inciardi JA, Surratt HL, Kurtz SP, Burke JJ. The diversion of prescription drugs by health care workers in Cincinnati, Ohio. Subst Use Misuse. 2006;41(2):255–64.CrossRefPubMed
15.
Zurück zum Zitat Kurtz SP, Buttram ME, Surratt HL. Vulnerable infected populations and street markets for ARVs: potential implications for PrEP rollout in the US. AIDS Care. 2014;26(4):411–5.CrossRefPubMed Kurtz SP, Buttram ME, Surratt HL. Vulnerable infected populations and street markets for ARVs: potential implications for PrEP rollout in the US. AIDS Care. 2014;26(4):411–5.CrossRefPubMed
16.
Zurück zum Zitat Liu AY, Kittredge PV, Vittinghoff E, Raymond HF, Ahrens K, Matheson T, et al. Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr. 2008;47(2):241–7.PubMed Liu AY, Kittredge PV, Vittinghoff E, Raymond HF, Ahrens K, Matheson T, et al. Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr. 2008;47(2):241–7.PubMed
17.
Zurück zum Zitat Mansergh G, Koblin BA, Colfax GN, McKirnan DJ, Flores SA, Hudson SM. Preefficacy use and sharing of antiretroviral medications to prevent sexually-transmitted HIV infection among US men who have sex with men. J Acquir Immune Defic Syndr. 2010;55(2):e14–6.CrossRefPubMed Mansergh G, Koblin BA, Colfax GN, McKirnan DJ, Flores SA, Hudson SM. Preefficacy use and sharing of antiretroviral medications to prevent sexually-transmitted HIV infection among US men who have sex with men. J Acquir Immune Defic Syndr. 2010;55(2):e14–6.CrossRefPubMed
18.
Zurück zum Zitat Mimiaga MJ, Case P, Johnson CV, Safren SA, Mayer KH. Pre-exposure antiretroviral prophylaxis (PrEP) attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience, but potential for increased utilization after education. J Acquir Immune Defic Syndr. 2009;50(1):77–83.CrossRefPubMedPubMedCentral Mimiaga MJ, Case P, Johnson CV, Safren SA, Mayer KH. Pre-exposure antiretroviral prophylaxis (PrEP) attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience, but potential for increased utilization after education. J Acquir Immune Defic Syndr. 2009;50(1):77–83.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Voetsch AC, Heffelfinger JD, Begley EB, Jafa-Bhushan K, Sullivan PS. Knowledge and use of preexposure and postexposure prophylaxis among attendees of minority gay pride events, 2005 through 2006. J Acquir Immune Defic Syndr. 2007;46(3):378–80.CrossRefPubMed Voetsch AC, Heffelfinger JD, Begley EB, Jafa-Bhushan K, Sullivan PS. Knowledge and use of preexposure and postexposure prophylaxis among attendees of minority gay pride events, 2005 through 2006. J Acquir Immune Defic Syndr. 2007;46(3):378–80.CrossRefPubMed
21.
Zurück zum Zitat Kurtz SP, Buttram ME. Misunderstanding of pre-exposure prophylaxis use among MSM: public health and policy implications. LGBT Health. 2016;3(6):461–4.CrossRefPubMedPubMedCentral Kurtz SP, Buttram ME. Misunderstanding of pre-exposure prophylaxis use among MSM: public health and policy implications. LGBT Health. 2016;3(6):461–4.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Philpott S. Social justice, public health ethics, and the use of HIV pre-exposure prophylaxis. Am J Prev Med. 2013;44(IS2):S137–40.CrossRefPubMed Philpott S. Social justice, public health ethics, and the use of HIV pre-exposure prophylaxis. Am J Prev Med. 2013;44(IS2):S137–40.CrossRefPubMed
23.
Zurück zum Zitat Koenig LJ, Lyles C, Smith DK. Adherence to antiretroviral medications for HIV pre-exposure prophylaxis: lessons learned from trials and treatment studies. Am J Prev Med. 2013;44(IS2):S91–8.CrossRefPubMed Koenig LJ, Lyles C, Smith DK. Adherence to antiretroviral medications for HIV pre-exposure prophylaxis: lessons learned from trials and treatment studies. Am J Prev Med. 2013;44(IS2):S91–8.CrossRefPubMed
24.
Zurück zum Zitat Liu A, Cohen S, Follansbee S, et al. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014;11(3):e1001613.CrossRefPubMedPubMedCentral Liu A, Cohen S, Follansbee S, et al. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014;11(3):e1001613.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Dimitrov D, Boily M-C, Mȃsse BR, Brown ER. Impact of pill sharing on drug resistance due to a wide-scale oral PrEP intervention in generalized epidemics. J AIDS Clin Res. 2012; Supplement 5(4). Dimitrov D, Boily M-C, Mȃsse BR, Brown ER. Impact of pill sharing on drug resistance due to a wide-scale oral PrEP intervention in generalized epidemics. J AIDS Clin Res. 2012; Supplement 5(4).
27.
Zurück zum Zitat Bernard RH. Research methods in anthropology: qualitative and quantitative approaches. New York: AltaMira Press; 2011. Bernard RH. Research methods in anthropology: qualitative and quantitative approaches. New York: AltaMira Press; 2011.
28.
Zurück zum Zitat Saldaña J. The coding manual for qualitative researchers. Los Angeles: Sage; 2013. Saldaña J. The coding manual for qualitative researchers. Los Angeles: Sage; 2013.
29.
30.
Zurück zum Zitat Centers for Disease Control and Prevention. HIV testing and risk behaviors among gay, bisexual, and other men who have sex with men—United States. Morb Mortal Wkly Rep. 2013;62(47):958–62. Centers for Disease Control and Prevention. HIV testing and risk behaviors among gay, bisexual, and other men who have sex with men—United States. Morb Mortal Wkly Rep. 2013;62(47):958–62.
33.
Zurück zum Zitat Surratt HL, Kurtz SP, Cicero TJ, O’Grady C, Levi-Minzi MA. Antiretroviral medication diversion among HIV-positive substance abusers in South Florida. Am J Public Health. 2013;103(6):1026–8.CrossRefPubMedPubMedCentral Surratt HL, Kurtz SP, Cicero TJ, O’Grady C, Levi-Minzi MA. Antiretroviral medication diversion among HIV-positive substance abusers in South Florida. Am J Public Health. 2013;103(6):1026–8.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Doblecki-Lewis S, Liu A, Feaster D, Cohen SE, Cardens G, Bacon O, et al. Healthcare access and PrEP continuation in San Francisco and Miami after US PrEP Demo Project. J Acquir Immune Defic Syndr. 2017;74(5):531–8.CrossRefPubMedPubMedCentral Doblecki-Lewis S, Liu A, Feaster D, Cohen SE, Cardens G, Bacon O, et al. Healthcare access and PrEP continuation in San Francisco and Miami after US PrEP Demo Project. J Acquir Immune Defic Syndr. 2017;74(5):531–8.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Galea JT, Cook R, Pickett J, Gorbach PM. PrEP in the wild: results from a global survey of medical providers’ PrEP practices in settings where it is approved and where it is not. In: 9th International AIDS Society Conference on HIV Science; July 23–26; Paris, France 2017. Galea JT, Cook R, Pickett J, Gorbach PM. PrEP in the wild: results from a global survey of medical providers’ PrEP practices in settings where it is approved and where it is not. In: 9th International AIDS Society Conference on HIV Science; July 23–26; Paris, France 2017.
36.
Zurück zum Zitat Galea J, Cook R, Pickett J, Gorbach PM. “PrEP in the wild”—preliminary results from a global survey on “informal” PrEP use in settings where it is approved and where it is not. HIV Research for Prevention; October 17–21; Chicago, IL 2016. Galea J, Cook R, Pickett J, Gorbach PM. “PrEP in the wild”—preliminary results from a global survey on “informal” PrEP use in settings where it is approved and where it is not. HIV Research for Prevention; October 17–21; Chicago, IL 2016.
37.
Zurück zum Zitat Buttram ME, Kurtz SP. Preliminary evidence of HIV seroconversion among HIV-negative men who have sex with men taking non-prescribed antiretrovirals for HIV prevention in Miami, Florida, USA. Sex Health. 2016;14(2):193–5.CrossRef Buttram ME, Kurtz SP. Preliminary evidence of HIV seroconversion among HIV-negative men who have sex with men taking non-prescribed antiretrovirals for HIV prevention in Miami, Florida, USA. Sex Health. 2016;14(2):193–5.CrossRef
38.
Zurück zum Zitat Molina JM, Capitant C, Spire B, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–46.CrossRefPubMed Molina JM, Capitant C, Spire B, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–46.CrossRefPubMed
39.
Zurück zum Zitat Lykins WR, Luecke E, Johengen D, van der Straten A, Desai TA. Long acting systemic HIV pre-exposure prophylaxis: an examination of the field. Drug Deliv Transl Res. 2017;7(6):805–16.CrossRefPubMed Lykins WR, Luecke E, Johengen D, van der Straten A, Desai TA. Long acting systemic HIV pre-exposure prophylaxis: an examination of the field. Drug Deliv Transl Res. 2017;7(6):805–16.CrossRefPubMed
Metadaten
Titel
Representations of Pre-exposure Prophylaxis, Informal Antiretroviral Medication Use for HIV Prevention, and Diversion on Geosocial Networking Apps among Men Who Have Sex with Men
verfasst von
Mance E. Buttram
Steven P. Kurtz
Publikationsdatum
25.09.2018
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 7/2019
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-018-2281-4

Weitere Artikel der Ausgabe 7/2019

AIDS and Behavior 7/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.